Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-060702
Filing Date
2023-11-08
Accepted
2023-11-08 08:30:26
Documents
61
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pepg-20230930.htm   iXBRL 10-Q 2746169
2 EX-31.1 pepg-ex31_1.htm EX-31.1 20400
3 EX-31.2 pepg-ex31_2.htm EX-31.2 19644
4 EX-32.1 pepg-ex32_1.htm EX-32.1 8991
5 EX-32.2 pepg-ex32_2.htm EX-32.2 9023
  Complete submission text file 0000950170-23-060702.txt   7588202

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pepg-20230930_def.xml EX-101.DEF 188201
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pepg-20230930.xsd EX-101.SCH 50482
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pepg-20230930_pre.xml EX-101.PRE 303005
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pepg-20230930_cal.xml EX-101.CAL 39732
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pepg-20230930_lab.xml EX-101.LAB 396557
55 EXTRACTED XBRL INSTANCE DOCUMENT pepg-20230930_htm.xml XML 911164
Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Filer) CIK: 0001835597 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41374 | Film No.: 231386115
SIC: 2834 Pharmaceutical Preparations